This genetic variant defines the APOE genotype, which has well‐known associations with CSF biomarkers related to Alzheimer's disease (AD), which were validated here (lower Aβ42, higher T‐tau and P‐tau (Chung et al, 2018)). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.